Related Experiment Video
Updated: May 8, 2026

BS3 Chemical Crosslinking Assay: Evaluating the Effect of Chronic Stress on Cell Surface GABAA Receptor Presentation in the Rodent Brain
Published on: May 26, 2023
Glial abnormalities in substance use disorders and depression: does shared glutamatergic dysfunction contribute to
Mark J Niciu1, Ioline D Henter, Gerard Sanacora
1Yale University Department of Psychiatry/Connecticut Mental Health Center (CMHC), Clinical Neuroscience Research Unit (CNRU) , New Haven, CT , USA.
Glial cells, including astrocytes, microglia, and oligodendrocytes, play crucial roles in mood and substance use disorders. Glutamatergic dysfunction mediated by glial cells is a shared pathway, suggesting therapeutic potential.
Area of Science:
- Neuroscience
- Psychiatry
- Cell Biology
Background:
- Neuropsychiatric disorders research has historically centered on neurons.
- Glial cells (astrocytes, microglia, oligodendrocytes) are increasingly recognized for their critical roles in mood and substance use disorders.
Purpose of the Study:
- To review the role of glial cells in the pathophysiology of comorbid mood and substance use disorders.
- To identify common neuropathological pathways involving glial cells in these conditions.
Main Methods:
- Systematic literature search of peer-reviewed articles in PubMed/Medline up to December 2012.
- Keywords included glial cells, specific glial types, substance use disorders, and glutamate.
Main Results:
- Comorbidity of depressive and substance use disorders suggests shared etiology.
- Key findings include reduced astrocyte numbers, altered glutamate neurotransmission, impaired neurotrophic factor production, microglial/neuroinflammatory pathology, and oligodendrocyte dysfunction leading to decreased myelination.
- These glial pathologies are evident in both depressive and substance use disorders.
Conclusions:
- Glial-mediated glutamatergic dysfunction represents a common neuropathological pathway in substance use and depressive disorders.
- Glutamatergic neuromodulation is a promising therapeutic target for this comorbidity.
Related Concept Videos
CNS Depressants: Alcohol and Nicotine
Gut-Brain Axis
Depression: Overview
Long-term Depression
Calcium Ion Concentration Mechanism
If over time, all...
Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within the...
Substance Use Disorders Affecting Sleep
Understanding the concepts of physical dependence,...
